The published literature describes BPC-157 as unusually stable for a peptide of its length, with the high proline content (five of fifteen residues) and absence of cysteine bridges cited as contributing factors
10 DuanL.LiangY.MaB.WangD.LiuW.HuangJ.et al (2017)
Dihexa peptide is currently not widely available as it is still under investigation and pending approval through clinical trials
Description Additional information BPC-157 10mg Bulk Kit Research Supply The BPC-157 10mg Bulk Kit 10 Pack is designed for laboratories and research professionals who require multiple vials for consistent experimental studies
Step 4: Follow up with your doctor Depending on which medications you are taking, youll have follow-up lab tests (typically every 90 days) and review the results with your doctor
Protocol design and informed consent dose, frequency, route, expected timeline, monitoring plan, and a clear acknowledgment that BPC-157 is not an FDA-approved finished drug